DOI: 10.1182/blood.v99.10.3661. Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia

Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia

10.1182/blood.v99.10.3661

Crossref journal-article

American Society of Hematology

Blood (234)

Abstract

The cytolytic function of natural killer (NK) cells is induced by the engagement of a series of activating receptors and coreceptors some of which have recently been identified and collectively termed natural cytotoxicity receptors (NCRs). Here, we analyzed the cytolytic function of NK cells obtained from patients with acute myeloid leukemia (AML). In sharp contrast with healthy donors, in most (16 of 18) patients with AML the majority of NK cells displayed low NCR surface density (NCRdull). This phenotype correlated with a weak cytolytic activity against autologous leukemic cells that could not be reversed by the monoclonal antibody-mediated disruption of HLA class I/killer immunoglobulinlike receptor interaction. The remaining 2 patients were characterized by NK cells having an NCRbright phenotype. Surprisingly, although displaying NCR-mediated cytolytic activity, these NCRbright NK cells were unable to kill autologous leukemic blasts. Importantly, the leukemic blasts from these 2 patients were also resistant to lysis mediated by normal NCRbrightallogeneic NK cells. Our study suggests that in most instances the inability of NK cells to kill autologous leukemic blasts is consequent to low NCR surface expression. In few cases, however, this failure appears to involve a mechanism of tumor escape based on down-regulation of ligands relevant for NCR-mediated target cell recognition.

Bibliography

Costello, R. T., Sivori, S., Marcenaro, E., Lafage-Pochitaloff, M., Mozziconacci, M.-J., Reviron, D., Gastaut, J.-A., Pende, D., Olive, D., & Moretta, A. (2002). Defective expression and function of natural killer cellâtriggering receptors in patients with acute myeloid leukemia. Blood, 99(10), 3661â3667.

Authors 10

Régis T. Costello (first)
Simona Sivori (additional)
Emanuela Marcenaro (additional)
Marina Lafage-Pochitaloff (additional)
Marie-Joelle Mozziconacci (additional)
Denis Reviron (additional)
Jean-Albert Gastaut (additional)
Daniela Pende (additional)
Daniel Olive (additional)
Alessandro Moretta (additional)

References 40 Referenced 389

10.1146/annurev.immunol.14.1.619 / Ann Rev Immunol. / Receptors for HLA class-I molecules in human natural killer cells. by Moretta (1996)
10.1146/annurev.immunol.17.1.875 / Ann Rev Immunol. / Regulation of immune response through inhibitory receptors. by Long (1999)
10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L / Eur J Immunol. / The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles. by Pende (1998)
10.1146/annurev.immunol.19.1.197 / Ann Rev Immunol. / Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis. by Moretta (2001)
10.1016/S0167-5699(96)10075-X / Immunol Today. / Implications for immunosurveillance of altered HLA class I phenotypes in human tumours. by Garrido (1997)
10.1016/S0167-5699(00)01596-6 / Immunol Today. / Natural cytotoxicity receptors that trigger human NK-mediated cytolysis. by Moretta (2000)
10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1 / Eur J Immunol. / NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells. by Sivori (1999)
10.1084/jem.190.10.1505 / J Exp Med. / Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells. by Pende (1999)
10.1126/science.285.5428.730 / Science. / An activating immunoreceptor complex formed by NKG2D and DAP10. by Wu (1999)
10.1073/pnas.95.11.6320 / Proc Natl Acad Sci U S A. / Murine NKG2d and CD94 are clustered within the natural killer complex and are expressed independently in natural killer cells. by Ho (1998)
10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y / Eur J Immunol. / Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin. by Pende (2001)
10.1126/science.285.5428.727 / Science. / Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. by Bauer (1999)
10.1016/S1074-7613(01)00095-4 / Immunity. / ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. by Cosman (2001)
10.1016/S1357-4310(99)01451-3 / Mol Med Today. / HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story. by Hicklin (1999)
10.1007/BF02912442 / Int J Clin Lab Res. / Altered MHC class I antigens in tumors. by Algarra (1997)
10.1111/j.1399-0039.1987.tb01583.x / Tissue Antigens. / HLA class I antigens on normal and leukemic cells (quantitative analysis). by Urlacher (1987)
{'key': '2020021215400942600_B17', 'first-page': '753', 'article-title': 'Expression of class I and class II markers on populations of leukemic cells.', 'volume': '34', 'author': 'Tongio', 'year': '1986', 'journal-title': 'Pathol Biol.'} / Pathol Biol. / Expression of class I and class II markers on populations of leukemic cells. by Tongio (1986)
10.1007/BF00205741 / Cancer Immunol Immunother. / Deficient expression of class-I HLA in some cases of acute leukemia. by Elkins (1984)
10.1016/S0145-2126(00)00053-9 / Leuk Res. / Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study. by Chambost (2000)
10.1172/JCI1268 / J Clin Invest. / Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation. by Asai (1998)
10.1111/j.1600-065X.1997.tb00981.x / Immunol Rev. / The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation. by Murphy (1997)
10.1007/s002770050246 / Ann Hematol. / Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation. by Jiang (1997)
10.1097/00007890-199506270-00016 / Transplantation. / Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice. by Zeis (1995)
10.1089/scd.1.1995.4.269 / J Hematother. / The role of natural killer cells in the treatment of chronic myeloid leukemia. by Silla (1995)
10.1046/j.1365-2141.1996.4991043.x / Br J Haematol. / Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets. by Silla (1996)
10.1182/blood.V87.6.2476.bloodjournal8762476 / Blood. / Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture. by Cervantes (1996)
10.1182/blood.V88.6.2279.bloodjournal8862279 / Blood. / CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis. by Pierson (1996)
10.3109/10428199509059647 / Leuk Lymphoma. / Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha. by Pawelec (1995)
10.1182/blood.V87.3.1113.bloodjournal8731113 / Blood. / BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells. by Roger (1996)
{'key': '2020021215400942600_B30', 'first-page': '478', 'article-title': 'Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia.', 'volume': '10', 'author': 'Tajima', 'year': '1996', 'journal-title': 'Leukemia.'} / Leukemia. / Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia. by Tajima (1996)
{'key': '2020021215400942600_B31', 'first-page': '999', 'article-title': 'Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.', 'volume': '9', 'author': 'Bendall', 'year': '1995', 'journal-title': 'Leukemia.'} / Leukemia. / Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells. by Bendall (1995)
10.1016/0753-3322(96)85286-3 / Biomed Pharmacother. / Role of natural effector cells in the prevention of radiation-induced leukemogenesis. by Datta (1996)
10.1128/JVI.69.2.1328-1333.1995 / J Virol. / Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses. by Feuer (1995)
10.1006/viro.1996.0643 / Virology. / HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice. by Stewart (1996)
{'key': '2020021215400942600_B35', 'first-page': '494', 'article-title': 'Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia.', 'volume': '10', 'author': 'Rossi', 'year': '1996', 'journal-title': 'Leukemia.'} / Leukemia. / Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. by Rossi (1996)
10.1046/j.1365-2141.1998.00654.x / Br J Haematol. / Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies. by Buggins (1998)
10.1182/blood.V88.1.236.236 / Blood. / T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28. by Renner (1996)
10.1126/science.1465616 / Science. / Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. by Mizoguchi (1992)
10.1002/ijc.2910610605 / Int J Cancer. / Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease. by Matsuda (1995)
10.1084/jem.188.5.953 / J Exp Med. / Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity. by Pessino (1998)

Dates

Type	When
Created	22 years, 10 months ago (Oct. 1, 2002, 5:48 p.m.)
Deposited	5 years, 6 months ago (Feb. 12, 2020, 3:40 p.m.)
Indexed	3 days, 5 hours ago (Aug. 24, 2025, 6:57 p.m.)
Issued	23 years, 3 months ago (May 15, 2002)
Published	23 years, 3 months ago (May 15, 2002)
Published Print	23 years, 3 months ago (May 15, 2002)

Funders 0

None

BibTeX

@article{Costello_2002, title={Defective expression and function of natural killer cell–triggering receptors in patients with acute myeloid leukemia}, volume={99}, ISSN={0006-4971}, url={http://dx.doi.org/10.1182/blood.v99.10.3661}, DOI={10.1182/blood.v99.10.3661}, number={10}, journal={Blood}, publisher={American Society of Hematology}, author={Costello, Régis T. and Sivori, Simona and Marcenaro, Emanuela and Lafage-Pochitaloff, Marina and Mozziconacci, Marie-Joelle and Reviron, Denis and Gastaut, Jean-Albert and Pende, Daniela and Olive, Daniel and Moretta, Alessandro}, year={2002}, month=may, pages={3661–3667} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        8,
        24
      ]
    ],
    "date-time": "2025-08-24T22:57:20Z",
    "timestamp": 1756076240659
  },
  "reference-count": 40,
  "publisher": "American Society of Hematology",
  "issue": "10",
  "content-domain": {
    "domain": [
      "ashpublications.org"
    ],
    "crossmark-restriction": true
  },
  "published-print": {
    "date-parts": [
      [
        2002,
        5,
        15
      ]
    ]
  },
  "abstract": "<jats:p>The cytolytic function of natural killer (NK) cells is induced by the engagement of a series of activating receptors and coreceptors some of which have recently been identified and collectively termed natural cytotoxicity receptors (NCRs). Here, we analyzed the cytolytic function of NK cells obtained from patients with acute myeloid leukemia (AML). In sharp contrast with healthy donors, in most (16 of 18) patients with AML the majority of NK cells displayed low NCR surface density (NCRdull). This phenotype correlated with a weak cytolytic activity against autologous leukemic cells that could not be reversed by the monoclonal antibody-mediated disruption of HLA class I/killer immunoglobulinlike receptor interaction. The remaining 2 patients were characterized by NK cells having an NCRbright phenotype. Surprisingly, although displaying NCR-mediated cytolytic activity, these NCRbright NK cells were unable to kill autologous leukemic blasts. Importantly, the leukemic blasts from these 2 patients were also resistant to lysis mediated by normal NCRbrightallogeneic NK cells. Our study suggests that in most instances the inability of NK cells to kill autologous leukemic blasts is consequent to low NCR surface expression. In few cases, however, this failure appears to involve a mechanism of tumor escape based on down-regulation of ligands relevant for NCR-mediated target cell recognition.</jats:p>",
  "DOI": "10.1182/blood.v99.10.3661",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        10,
        1
      ]
    ],
    "date-time": "2002-10-01T21:48:18Z",
    "timestamp": 1033508898000
  },
  "page": "3661-3667",
  "update-policy": "http://dx.doi.org/10.1182/blood.2019cm0000",
  "source": "Crossref",
  "is-referenced-by-count": 389,
  "title": "Defective expression and function of natural killer cell\u2013triggering receptors in patients with acute myeloid leukemia",
  "prefix": "10.1182",
  "volume": "99",
  "author": [
    {
      "given": "Re\u0301gis T.",
      "family": "Costello",
      "sequence": "first",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Simona",
      "family": "Sivori",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Emanuela",
      "family": "Marcenaro",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Marina",
      "family": "Lafage-Pochitaloff",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Marie-Joelle",
      "family": "Mozziconacci",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Denis",
      "family": "Reviron",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Jean-Albert",
      "family": "Gastaut",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Daniela",
      "family": "Pende",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Daniel",
      "family": "Olive",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    },
    {
      "given": "Alessandro",
      "family": "Moretta",
      "sequence": "additional",
      "affiliation": [
        {
          "name": "From the Unite\u0301 d'Immunologie des Tumeurs De\u0301partement d'He\u0301matologie, Institut Paoli-Calmettes; Unite\u0301 d'Immuno-Ge\u0301ne\u0301tique, Centre de Transfusion Sanguine, and Unite\u0301 INSERM U119, Universite\u0301 de la Me\u0301diterrane\u0301e, Marseille, France; Laboratorio di Immunologia Molecolare, Dipartimento di Medicina Sperimentale, Sezione Istologia, Universita\u0300 degli Studi di Genova, Italy; and U.O. Immunologia, Istituto Scientifico Tumori, Genova, Italy."
        }
      ]
    }
  ],
  "member": "234",
  "reference": [
    {
      "key": "2020021215400942600_B1",
      "doi-asserted-by": "crossref",
      "first-page": "619",
      "DOI": "10.1146/annurev.immunol.14.1.619",
      "article-title": "Receptors for HLA class-I molecules in human natural killer cells.",
      "volume": "14",
      "author": "Moretta",
      "year": "1996",
      "journal-title": "Ann Rev Immunol."
    },
    {
      "key": "2020021215400942600_B2",
      "doi-asserted-by": "crossref",
      "first-page": "904",
      "DOI": "10.1146/annurev.immunol.17.1.875",
      "article-title": "Regulation of immune response through inhibitory receptors.",
      "volume": "17",
      "author": "Long",
      "year": "1999",
      "journal-title": "Ann Rev Immunol."
    },
    {
      "key": "2020021215400942600_B3",
      "doi-asserted-by": "crossref",
      "first-page": "2384",
      "DOI": "10.1002/(SICI)1521-4141(199808)28:08<2384::AID-IMMU2384>3.0.CO;2-L",
      "article-title": "The susceptibility to natural killer cell-mediated lysis of HLA class I-positive melanomas reflects the expression of insufficient amounts of different HLA class I alleles.",
      "volume": "28",
      "author": "Pende",
      "year": "1998",
      "journal-title": "Eur J Immunol."
    },
    {
      "key": "2020021215400942600_B4",
      "doi-asserted-by": "crossref",
      "first-page": "197",
      "DOI": "10.1146/annurev.immunol.19.1.197",
      "article-title": "Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.",
      "volume": "19",
      "author": "Moretta",
      "year": "2001",
      "journal-title": "Ann Rev Immunol."
    },
    {
      "key": "2020021215400942600_B5",
      "doi-asserted-by": "crossref",
      "first-page": "89",
      "DOI": "10.1016/S0167-5699(96)10075-X",
      "article-title": "Implications for immunosurveillance of altered HLA class I phenotypes in human tumours.",
      "volume": "18",
      "author": "Garrido",
      "year": "1997",
      "journal-title": "Immunol Today."
    },
    {
      "key": "2020021215400942600_B6",
      "doi-asserted-by": "crossref",
      "first-page": "228",
      "DOI": "10.1016/S0167-5699(00)01596-6",
      "article-title": "Natural cytotoxicity receptors that trigger human NK-mediated cytolysis.",
      "volume": "21",
      "author": "Moretta",
      "year": "2000",
      "journal-title": "Immunol Today."
    },
    {
      "key": "2020021215400942600_B7",
      "doi-asserted-by": "crossref",
      "first-page": "1656",
      "DOI": "10.1002/(SICI)1521-4141(199905)29:05<1656::AID-IMMU1656>3.0.CO;2-1",
      "article-title": "NKp46 is the major triggering receptor involved in the natural cytotoxicity of fresh or cultured human NK cells. Correlation between surface density of NKp46 and natural cytotoxicity against autologous, allogeneic or xenogeneic target cells.",
      "volume": "29",
      "author": "Sivori",
      "year": "1999",
      "journal-title": "Eur J Immunol."
    },
    {
      "key": "2020021215400942600_B8",
      "doi-asserted-by": "crossref",
      "first-page": "1505",
      "DOI": "10.1084/jem.190.10.1505",
      "article-title": "Identification and molecular characterization of NKp30, a novel triggering receptor involved in natural cytotoxicity mediated by human natural killer cells.",
      "volume": "190",
      "author": "Pende",
      "year": "1999",
      "journal-title": "J Exp Med."
    },
    {
      "key": "2020021215400942600_B9",
      "doi-asserted-by": "crossref",
      "first-page": "730",
      "DOI": "10.1126/science.285.5428.730",
      "article-title": "An activating immunoreceptor complex formed by NKG2D and DAP10.",
      "volume": "285",
      "author": "Wu",
      "year": "1999",
      "journal-title": "Science."
    },
    {
      "key": "2020021215400942600_B10",
      "doi-asserted-by": "crossref",
      "first-page": "6320",
      "DOI": "10.1073/pnas.95.11.6320",
      "article-title": "Murine NKG2d and CD94 are clustered within the natural killer complex and are expressed independently in natural killer cells.",
      "volume": "95",
      "author": "Ho",
      "year": "1998",
      "journal-title": "Proc Natl Acad Sci U S A."
    },
    {
      "key": "2020021215400942600_B11",
      "doi-asserted-by": "crossref",
      "first-page": "1076",
      "DOI": "10.1002/1521-4141(200104)31:4<1076::AID-IMMU1076>3.0.CO;2-Y",
      "article-title": "Role of NKG2D in tumor cell lysis mediated by human NK cells: cooperation with natural cytotoxicity receptors and capability of recognizing tumors of nonepithelial origin.",
      "volume": "31",
      "author": "Pende",
      "year": "2001",
      "journal-title": "Eur J Immunol."
    },
    {
      "key": "2020021215400942600_B12",
      "doi-asserted-by": "crossref",
      "first-page": "727",
      "DOI": "10.1126/science.285.5428.727",
      "article-title": "Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA.",
      "volume": "285",
      "author": "Bauer",
      "year": "1999",
      "journal-title": "Science."
    },
    {
      "key": "2020021215400942600_B13",
      "doi-asserted-by": "crossref",
      "first-page": "123",
      "DOI": "10.1016/S1074-7613(01)00095-4",
      "article-title": "ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor.",
      "volume": "14",
      "author": "Cosman",
      "year": "2001",
      "journal-title": "Immunity."
    },
    {
      "key": "2020021215400942600_B14",
      "doi-asserted-by": "crossref",
      "first-page": "178",
      "DOI": "10.1016/S1357-4310(99)01451-3",
      "article-title": "HLA class I antigen downregulation in human cancers: T-cell immunotherapy revives an old story.",
      "volume": "5",
      "author": "Hicklin",
      "year": "1999",
      "journal-title": "Mol Med Today."
    },
    {
      "key": "2020021215400942600_B15",
      "doi-asserted-by": "crossref",
      "first-page": "95",
      "DOI": "10.1007/BF02912442",
      "article-title": "Altered MHC class I antigens in tumors.",
      "volume": "27",
      "author": "Algarra",
      "year": "1997",
      "journal-title": "Int J Clin Lab Res."
    },
    {
      "key": "2020021215400942600_B16",
      "doi-asserted-by": "crossref",
      "first-page": "237",
      "DOI": "10.1111/j.1399-0039.1987.tb01583.x",
      "article-title": "HLA class I antigens on normal and leukemic cells (quantitative analysis).",
      "volume": "29",
      "author": "Urlacher",
      "year": "1987",
      "journal-title": "Tissue Antigens."
    },
    {
      "key": "2020021215400942600_B17",
      "first-page": "753",
      "article-title": "Expression of class I and class II markers on populations of leukemic cells.",
      "volume": "34",
      "author": "Tongio",
      "year": "1986",
      "journal-title": "Pathol Biol."
    },
    {
      "key": "2020021215400942600_B18",
      "doi-asserted-by": "crossref",
      "first-page": "91",
      "DOI": "10.1007/BF00205741",
      "article-title": "Deficient expression of class-I HLA in some cases of acute leukemia.",
      "volume": "18",
      "author": "Elkins",
      "year": "1984",
      "journal-title": "Cancer Immunol Immunother."
    },
    {
      "key": "2020021215400942600_B19",
      "doi-asserted-by": "crossref",
      "first-page": "823",
      "DOI": "10.1016/S0145-2126(00)00053-9",
      "article-title": "Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study.",
      "volume": "24",
      "author": "Chambost",
      "year": "2000",
      "journal-title": "Leuk Res."
    },
    {
      "key": "2020021215400942600_B20",
      "doi-asserted-by": "crossref",
      "first-page": "1835",
      "DOI": "10.1172/JCI1268",
      "article-title": "Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.",
      "volume": "101",
      "author": "Asai",
      "year": "1998",
      "journal-title": "J Clin Invest."
    },
    {
      "key": "2020021215400942600_B21",
      "doi-asserted-by": "crossref",
      "first-page": "167",
      "DOI": "10.1111/j.1600-065X.1997.tb00981.x",
      "article-title": "The potential role of NK cells in the separation of graft-versus-tumor effects from graft-versus-host disease after allogeneic bone marrow transplantation.",
      "volume": "157",
      "author": "Murphy",
      "year": "1997",
      "journal-title": "Immunol Rev."
    },
    {
      "key": "2020021215400942600_B22",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1007/s002770050246",
      "article-title": "Association of natural killer cell immune recovery with a graft-versus-leukemia effect independent of graft-versus-host disease following allogeneic bone marrow transplantation.",
      "volume": "74",
      "author": "Jiang",
      "year": "1997",
      "journal-title": "Ann Hematol."
    },
    {
      "key": "2020021215400942600_B23",
      "doi-asserted-by": "crossref",
      "first-page": "1734",
      "DOI": "10.1097/00007890-199506270-00016",
      "article-title": "Allogeneic NK cells as potent antileukemic effector cells after allogeneic bone marrow transplantation in mice.",
      "volume": "59",
      "author": "Zeis",
      "year": "1995",
      "journal-title": "Transplantation."
    },
    {
      "key": "2020021215400942600_B24",
      "doi-asserted-by": "crossref",
      "first-page": "269",
      "DOI": "10.1089/scd.1.1995.4.269",
      "article-title": "The role of natural killer cells in the treatment of chronic myeloid leukemia.",
      "volume": "4",
      "author": "Silla",
      "year": "1995",
      "journal-title": "J Hematother."
    },
    {
      "key": "2020021215400942600_B25",
      "doi-asserted-by": "crossref",
      "first-page": "375",
      "DOI": "10.1046/j.1365-2141.1996.4991043.x",
      "article-title": "Generation of activated natural killer (A-NK) cells in patients with chronic myelogenous leukaemia and their role in the in vitro disappearance of BCR/abl-positive targets.",
      "volume": "93",
      "author": "Silla",
      "year": "1996",
      "journal-title": "Br J Haematol."
    },
    {
      "key": "2020021215400942600_B26",
      "doi-asserted-by": "crossref",
      "first-page": "2476",
      "DOI": "10.1182/blood.V87.6.2476.bloodjournal8762476",
      "article-title": "Autologous activated natural killer cells suppress primitive chronic myelogenous leukemia progenitors in long-term culture.",
      "volume": "87",
      "author": "Cervantes",
      "year": "1996",
      "journal-title": "Blood."
    },
    {
      "key": "2020021215400942600_B27",
      "doi-asserted-by": "crossref",
      "first-page": "2279",
      "DOI": "10.1182/blood.V88.6.2279.bloodjournal8862279",
      "article-title": "CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.",
      "volume": "88",
      "author": "Pierson",
      "year": "1996",
      "journal-title": "Blood."
    },
    {
      "key": "2020021215400942600_B28",
      "doi-asserted-by": "crossref",
      "first-page": "471",
      "DOI": "10.3109/10428199509059647",
      "article-title": "Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha.",
      "volume": "18",
      "author": "Pawelec",
      "year": "1995",
      "journal-title": "Leuk Lymphoma."
    },
    {
      "key": "2020021215400942600_B29",
      "doi-asserted-by": "crossref",
      "first-page": "1113",
      "DOI": "10.1182/blood.V87.3.1113.bloodjournal8731113",
      "article-title": "BCR-ABL does not prevent apoptotic death induced by human natural killer or lymphokine-activated killer cells.",
      "volume": "87",
      "author": "Roger",
      "year": "1996",
      "journal-title": "Blood."
    },
    {
      "key": "2020021215400942600_B30",
      "first-page": "478",
      "article-title": "Natural killer cell activity and cytokine production as prognostic factors in adult acute leukemia.",
      "volume": "10",
      "author": "Tajima",
      "year": "1996",
      "journal-title": "Leukemia."
    },
    {
      "key": "2020021215400942600_B31",
      "first-page": "999",
      "article-title": "Natural killer cells adhere to bone marrow fibroblasts and inhibit adhesion of acute myeloid leukemia cells.",
      "volume": "9",
      "author": "Bendall",
      "year": "1995",
      "journal-title": "Leukemia."
    },
    {
      "key": "2020021215400942600_B32",
      "doi-asserted-by": "crossref",
      "first-page": "125",
      "DOI": "10.1016/0753-3322(96)85286-3",
      "article-title": "Role of natural effector cells in the prevention of radiation-induced leukemogenesis.",
      "volume": "50",
      "author": "Datta",
      "year": "1996",
      "journal-title": "Biomed Pharmacother."
    },
    {
      "key": "2020021215400942600_B33",
      "doi-asserted-by": "crossref",
      "first-page": "1328",
      "DOI": "10.1128/JVI.69.2.1328-1333.1995",
      "article-title": "Potential role of natural killer cells in controlling tumorigenesis by human T-cell leukemia viruses.",
      "volume": "69",
      "author": "Feuer",
      "year": "1995",
      "journal-title": "J Virol."
    },
    {
      "key": "2020021215400942600_B34",
      "doi-asserted-by": "crossref",
      "first-page": "167",
      "DOI": "10.1006/viro.1996.0643",
      "article-title": "HTLV-1 gene expression in adult T-cell leukemia cells elicits an NK cell response in vitro and correlates with cell rejection in SCID mice.",
      "volume": "226",
      "author": "Stewart",
      "year": "1996",
      "journal-title": "Virology."
    },
    {
      "key": "2020021215400942600_B35",
      "first-page": "494",
      "article-title": "Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia.",
      "volume": "10",
      "author": "Rossi",
      "year": "1996",
      "journal-title": "Leukemia."
    },
    {
      "key": "2020021215400942600_B36",
      "doi-asserted-by": "crossref",
      "first-page": "784",
      "DOI": "10.1046/j.1365-2141.1998.00654.x",
      "article-title": "Variable expression of CD3-zeta and associated protein tyrosine kinases in lymphocytes from patients with myeloid malignancies.",
      "volume": "100",
      "author": "Buggins",
      "year": "1998",
      "journal-title": "Br J Haematol."
    },
    {
      "key": "2020021215400942600_B37",
      "doi-asserted-by": "crossref",
      "first-page": "236",
      "DOI": "10.1182/blood.V88.1.236.236",
      "article-title": "T cells from patients with Hodgkin's disease have a defective T-cell receptor zeta chain expression that is reversible by T-cell stimulation with CD3 and CD28.",
      "volume": "88",
      "author": "Renner",
      "year": "1996",
      "journal-title": "Blood."
    },
    {
      "key": "2020021215400942600_B38",
      "doi-asserted-by": "crossref",
      "first-page": "1795",
      "DOI": "10.1126/science.1465616",
      "article-title": "Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice.",
      "volume": "258",
      "author": "Mizoguchi",
      "year": "1992",
      "journal-title": "Science."
    },
    {
      "key": "2020021215400942600_B39",
      "doi-asserted-by": "crossref",
      "first-page": "765",
      "DOI": "10.1002/ijc.2910610605",
      "article-title": "Alterations in the signal-transducing molecules of T cells and NK cells in colorectal tumor-infiltrating, gut mucosal and peripheral lymphocytes: correlation with the stage of the disease.",
      "volume": "61",
      "author": "Matsuda",
      "year": "1995",
      "journal-title": "Int J Cancer."
    },
    {
      "key": "2020021215400942600_B40",
      "doi-asserted-by": "crossref",
      "first-page": "953",
      "DOI": "10.1084/jem.188.5.953",
      "article-title": "Molecular cloning of NKp46: a novel member of the immunoglobulin superfamily involved in triggering of natural cytotoxicity.",
      "volume": "188",
      "author": "Pessino",
      "year": "1998",
      "journal-title": "J Exp Med."
    }
  ],
  "container-title": "Blood",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "http://ashpublications.org/blood/article-pdf/99/10/3661/1684764/h81002003661.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "syndication"
    },
    {
      "URL": "http://ashpublications.org/blood/article-pdf/99/10/3661/1684764/h81002003661.pdf",
      "content-type": "unspecified",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2020,
        2,
        12
      ]
    ],
    "date-time": "2020-02-12T20:40:22Z",
    "timestamp": 1581540022000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://ashpublications.org/blood/article/99/10/3661/107008/Defective-expression-and-function-of-natural"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2002,
        5,
        15
      ]
    ]
  },
  "references-count": 40,
  "journal-issue": {
    "issue": "10",
    "published-print": {
      "date-parts": [
        [
          2002,
          5,
          15
        ]
      ]
    }
  },
  "URL": "http://dx.doi.org/10.1182/blood.V99.10.3661",
  "relation": {},
  "ISSN": [
    "1528-0020",
    "0006-4971"
  ],
  "subject": [],
  "published": {
    "date-parts": [
      [
        2002,
        5,
        15
      ]
    ]
  }
}